A Clinical Study to Evaluate the Efficacy and Safety of Antiviral Therapy in Chronic Hepatitis B Patients with HBsAg <=1,000 IU/ml, with or without Metabolic-Associated Fatty Liver Disease (MAFLD)

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: a06c374d3d080bd3825c9df93f92a3210fae66b1
First added on: Sep 12, 2026